BioDelivery Sciences Inte... (BDSI)
NASDAQ: BDSI
· Real-Time Price · USD
5.59
-0.00 (-0.09%)
At close: Mar 22, 2022, 9:00 PM
BioDelivery Sciences International Revenue Breakdown
| Period Ending | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Belbuca Revenue | 38.35M | 36.93M | 36.5M | 36.4M | 35.56M | 34.76M | 32.34M | 33.47M | 28.26M | 26.51M | 24.06M | 18.7M | 15.86M | 12.36M | 9.75M | 8.02M | 9.43M | 6.44M | 6.56M |
| Belbuca Revenue Growth | +3.85% | +1.17% | +0.28% | +2.38% | +2.30% | +7.46% | -3.36% | +18.43% | +6.59% | +10.20% | +28.64% | +17.93% | +28.34% | +26.80% | +21.46% | -14.87% | +46.43% | -1.92% | n/a |
| Product Revenue | 42.2M | 41.07M | 40.52M | 40.8M | 41.63M | 38.78M | 36.45M | 4.18M | 30.45M | 29.62M | 28.06M | 19.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Revenue Growth | +2.74% | +1.35% | -0.69% | -1.98% | +7.33% | +6.42% | +772.10% | -86.28% | +2.79% | +5.59% | +41.99% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Symproic Revenue | 3.85M | 4.14M | 4.02M | 4.4M | 3.66M | 3.45M | 3.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Symproic Revenue Growth | -7.15% | +3.06% | -8.70% | +20.14% | +6.11% | +1.17% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 27.2M | 25.47M | 25.78M | 27.76M | 21.42M | 22.46M | 28.21M | 26.74M | 23.76M | 23.36M | 21.95M | 16.99M | 17.59M | 13.49M | 14.02M | 13.51M | 14.78M | 14.87M | 15.97M | 13.26M | 11.74M | 12.05M | 12.5M | 13.05M | 13.5M | 14.71M | 13.29M | 13.18M |
| Selling, General, and Administrative Revenue Growth | +6.80% | -1.21% | -7.14% | +29.61% | -4.64% | -20.38% | +5.52% | +12.53% | +1.71% | +6.40% | +29.23% | -3.41% | +30.40% | -3.79% | +3.82% | -8.60% | -0.62% | -6.91% | +20.45% | +12.95% | -2.61% | -3.54% | -4.28% | -3.30% | -8.26% | +10.75% | +0.80% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 865K | 699K | 854K | 2.48M | 6.79M | 1.99M | 1.59M | 2.67M | 5.09M | 4.4M | 4.01M | 5.38M | 5.1M | 4.47M | 4.51M | 6.55M |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | +23.75% | -18.15% | -65.62% | -63.44% | +242.09% | +24.91% | -40.47% | -47.55% | +15.67% | +9.83% | -25.46% | +5.49% | +13.95% | -0.73% | -31.20% | n/a |